Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net loss $ (3,694,927) $ (940,935)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of debt discount 2,509,471 37,112
Loss on shares issued for legal settlement 78,104
Common stock issued for settlement of payables 239,815
Common stock issued for legal settlements 74,053
Credit loss expense 35,200 25,500
Changes in operating assets and liabilities:    
Accounts receivable (274,200) (267,603)
Prepaid expenses and other assets (13,297) (5,850)
Accounts payable and accrued liabilities (99,802) 107,298
Deferred revenue 44,917 (219,250)
Net cash used in operating activities (1,414,534) (949,860)
Net cash from investing activities:
Cash flows from financing activities:    
Proceeds from loans payable, net 1,385,000 994,500
Payments on loans payable (27,369) (48,410)
Proceeds from the exercise of warrants, net of costs 702,166  
Payments on shareholder advance (67,622)
Proceeds from accounts payable and accrued liabilities - related party 128,479
Payments on accounts payable and accrued liabilities - related party (128,479)
Net cash provided by financing activities 1,992,175 946,090
Net increase (decrease) in cash 577,641 (3,770)
Cash, beginning of period 106,654 91,436
Cash, end of period 684,295 87,666
Supplemental disclosures of cash flow information:    
Cash paid for interest 73 30,499
Cash paid for income taxes
Non-cash investing and financing activities:    
Shares issued for vested restricted stock units 2
Shares issued for conversion of convertible loans and interest 2,753,479
Shares issued for accrued legal settlement 283,906 285,294
Warrants issued in conjunction with convertible loans 1,385,000 973,200
Warrants issued in conjunction with inducement agreement $ 1,053,427